Optimizing antiresorptive treatment in patients with bone metastases: time to initiation, switching strategies, and treatment duration

PURPOSE: The aim of this study was to investigate the optimal use of antiresorptive therapy in patients with metastatic cancer in terms of time to treatment initiation, switching strategy in case of skeletal-related event (SRE) or skeletal disease progression, and treatment efficacy beyond 2 years....

Descripción completa

Detalles Bibliográficos
Autores principales: Mjelstad, AnneMarthe, Zakariasson, Gustav, Valachis, Antonis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726664/
https://www.ncbi.nlm.nih.gov/pubmed/30759277
http://dx.doi.org/10.1007/s00520-019-04676-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726664/
https://www.ncbi.nlm.nih.gov/pubmed/30759277
http://dx.doi.org/10.1007/s00520-019-04676-6

Ejemplares similares